Microvascular obstruction (MVO) is a recognised phenomenon following mechanical
reperfusion in patients presenting with ST-segment elevation myocardial infarction (STEMI) …

Background The no-reflow phenomenon affects about one out of five patients undergoing
Primary Percutaneous Coronary Intervention (PPCI). As the prolonged no-reflow …

Methods: Using relevant key terms, we systematically searched MEDLINE, Scopus, Embase,
and Web of Science to find relevant studies up to February 5 th, 2023. Effect sizes in each …

Primary percutaneous coronary intervention (PCI) is one of the most effective treatment
modalities for acute life-threatening diseases. Although successful PCI provides a direct …

The no-reflow phenomenon (NR) is a rare but feared complication of percutaneous coronary
interventions (PCI)(1-6). ST-segment elevation myocardial infarction (STEMI) is the most …

DISCUSSION Page 1 www.PRSGlobalOpen.com 1 Discussion: Successful Use of WALANT in
Local and Regional Soft Tissue Flaps: A Case Series Donald H. Lalonde, MD This article from …

Background: The no-reflow phenomenon affects about one out of five patients undergoing
Primary Percutaneous Coronary Intervention (PPCI). As the prolonged no-reflow …

Objectives: This study aimed to determine the incidence, predictors, and clinical outcomes of
slow flow and no reflow (SF/NR) in patients undergoing a pharmacoinvasive strategy …

Objectives: This study aimed to compare the efficacy of intracoronary verapamil versus
adenosine in managing the no-reflow phenomenon in normotensive patients with acute …